Glooko announced today that it entered into a partnership with Sanofi to integrate a connected device for insulin pens into its digital platform.
SoloSmart, a single-piece, add-on connected device works with Sanofi’s SoloStar and DoubleStar insulin injection pens. It records the insulin dose, date and time of injection. Through this partnership, the company’s can offer data visualization through the Glooko app. Patients can share data with healthcare professionals for connected care in their diabetes management.
Get the full story at our sister site, Drug Delivery Business News.